IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management (NACHO)
This study is currently recruiting participants.
Verified November 2015 by Society for the Advancement of Blood Management, Inc
Sponsor:
Society for the Advancement of Blood Management, Inc
Information provided by (Responsible Party):
Society for the Advancement of Blood Management, Inc
ClinicalTrials.gov Identifier:
NCT01686659
First received: August 29, 2012
Last updated: November 27, 2015
Last verified: November 2015
| Tracking Information | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | August 29, 2012 | |||||||||
| Last Updated Date | November 27, 2015 | |||||||||
| Start Date ICMJE | September 2012 | |||||||||
| Estimated Primary Completion Date | September 2016 (Final data collection date for primary outcome measure) | |||||||||
| Current Primary Outcome Measures ICMJE |
Amount of Intraoperative RBC Transfusion [ Time Frame: From the first surgical incision to the wound closure ] Number of allogeneic RBC units transfused intraoperatively per patient |
|||||||||
| Original Primary Outcome Measures ICMJE | Same as current | |||||||||
| Change History | Complete list of historical versions of study NCT01686659 on ClinicalTrials.gov Archive Site | |||||||||
| Current Secondary Outcome Measures ICMJE |
|
|||||||||
| Original Secondary Outcome Measures ICMJE | Same as current | |||||||||
| Current Other Outcome Measures ICMJE | Not Provided | |||||||||
| Original Other Outcome Measures ICMJE | Not Provided | |||||||||
| Descriptive Information | ||||||||||
| Brief Title ICMJE | Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management | |||||||||
| Official Title ICMJE | Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management | |||||||||
| Brief Summary | This is a multi-center cluster-randomized trial with the following Specific Aims:
Accordingly, the study hypotheses are defined as follows:
|
|||||||||
| Detailed Description | This is a matched-pair cluster-randomized controlled trial. At each participating centers, consenting eligible Anesthesiologists will be grouped into matched pairs based on their practice characteristics and experience (namely, their main surgical service/procedures and their years of experience working as a clinician responsible for making transfusion decisions). From each pair, Anesthesiologists will be randomly allocated to either treat their patients while having access to data from a continuous noninvasive hemoglobin monitoring device (total hemoglobin [SpHb] and Pleth Variability Index [PVI]) (SpHb group) or without access to SpHb/PVI data, under standard of care (control group). Regardless of randomization, all patients will be monitored with the device but the data will be blinded and not be available to the Anesthesiologist to be used in the management of the control group. Only in the SpHb group, the SpHb/PVI data will be provided live to the Anesthesiologist, to be used during management of the patients. | |||||||||
| Study Type ICMJE | Interventional | |||||||||
| Study Phase | Not Provided | |||||||||
| Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Diagnostic |
|||||||||
| Condition ICMJE | Surgery | |||||||||
| Intervention ICMJE | Device: Continuous Noninvasive Hemoglobin Monitoring
Availability of data from a continuous noninvasive hemoglobin monitoring device (total hemoglobin [SpHb] and Pleth Variability Index [PVI]) to the clinicians in the operating room
Other Names:
|
|||||||||
| Study Arms |
|
|||||||||
| Publications * | Not Provided | |||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||||||||
| Recruitment Information | ||||||||||
| Recruitment Status ICMJE | Recruiting | |||||||||
| Estimated Enrollment ICMJE | 470 | |||||||||
| Estimated Completion Date | March 2017 | |||||||||
| Estimated Primary Completion Date | September 2016 (Final data collection date for primary outcome measure) | |||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
|||||||||
| Sex/Gender |
|
|||||||||
| Ages | 18 Years and older (Adult, Senior) | |||||||||
| Accepts Healthy Volunteers | No | |||||||||
| Contacts ICMJE |
|
|||||||||
| Listed Location Countries ICMJE | France, Italy, Japan, United States | |||||||||
| Removed Location Countries | ||||||||||
| Administrative Information | ||||||||||
| NCT Number ICMJE | NCT01686659 | |||||||||
| Other Study ID Numbers ICMJE | NACHO | |||||||||
| Has Data Monitoring Committee | Yes | |||||||||
| U.S. FDA-regulated Product | Not Provided | |||||||||
| Plan to Share Data | Not Provided | |||||||||
| IPD Description | Not Provided | |||||||||
| Responsible Party | Society for the Advancement of Blood Management, Inc | |||||||||
| Study Sponsor ICMJE | Society for the Advancement of Blood Management, Inc | |||||||||
| Collaborators ICMJE | Not Provided | |||||||||
| Investigators ICMJE |
|
|||||||||
| PRS Account | Society for the Advancement of Blood Management, Inc | |||||||||
| Verification Date | November 2015 | |||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
||||||||||